Biobarica

What Biobarica does

Biobarica (legal entity Europe Medical Treat LLC, Delaware) manufactures and globally distributes the Revitalair® 430, a medium-pressure semi-rigid monoplace hyperbaric oxygen therapy chamber operating at 1.5 atmospheres absolute (ATA). The chamber is differentiated by a zipperless closure, dual relief valves, a 5-minute pressurization cycle, 10 windows providing 360-degree visibility, and a removable stretcher for patients with reduced mobility. The 1.5 ATA pressure point is positioned as safer than higher-pressure alternatives for neurological and pediatric applications while retaining therapeutic efficacy. Hyperbaric medicine delivers pressurized oxygen via mask inside an air-pressurized cabin, eliminating oxygen-fire accumulation risks associated with oxygen-filled chambers.

The company sells an integrated treatment system rather than a standalone device: every chamber is bundled with the Biobarica Global System (BGS), a cloud practice-management suite covering appointment scheduling, patient CRM, telemedicine, real-time equipment monitoring, training modules, and Hipermed, a network-wide outcomes statistics module. Adjacent offerings include Biobarica Media (an educational content platform with 27+ physician interview episodes), Biobarica Customer Care (extended warranty, preventive diagnostics, upgrade and recycling programs), and Biobarica Financial Services (BFS), an in-house financing program with 2-4 hour credit approvals that processes over $10 million annually. Hardware is certified as a medical device by FDA (US), CE (Europe), ANMAT (Argentina), and COFEPRIS (Mexico), with approvals in more than a dozen additional countries.

Commercially, Biobarica runs a quote-based enterprise sales motion combining direct inside sales (driven by 'Request a demo' and 'Free Virtual Demo' CTAs) with a network of authorized distributors and country-level operational representatives. End customers are private medical practices, hospitals and multi-center networks, wellness and aesthetic clinics, and rehabilitation and sports-medicine facilities; plastic surgery — particularly in Mexico's medical-tourism corridor — is the most heavily evidenced vertical, with documented cases of recovery time cut from 21 days to 10 days, zero infections, and zero wound dehiscence after systematic HBOT protocols. Biobarica claims 1,000+ care centers, 2,000+ physicians, and 2+ million patients treated across 60+ countries, founded circa 2009-2010, with 51-100 employees and operational presence tied to Argentina and Miami.

Name

Biobarica

Legal name

Europe Medical Treat LLC

Website

https://biobarica.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Biobarica manufactures and globally distributes the Revitalair 430, a medium-pressure (1.5 ATA) semi-rigid hyperbaric oxygen therapy chamber, sold as an integrated system with BGS practice-management software, clinical training, financing, and ongoing technical support to medical practices, hospitals, wellness centers, and rehabilitation clinics across 60+ countries.

Ownership category

akta.pro rank

Product category

Hyperbaric Oxygen Therapy Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Ambulatory Wound Care & Hyperbaric Oxygen Therapy Centers (HLAFABAG)

Keywords

• Hyperbaric oxygen therapy
• Hyperbaric chamber manufacturing
• Medical practice management software
• Postoperative recovery devices
• Wound care equipment

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Hyperbaric Chamber Hardware Sales: Sale of Revitalair® 430 hyperbaric chambers to medical institutions, clinics, and private practices. The chambers are sold as complete systems including the semi-rigid cabin and compression system/compressor cabinet. Installation, training, and initial support are bundled with hardware purchase.
2. Biobarica Global System (BGS) Software Subscription: Cloud-based management platform provided to all chamber owners as part of the system. While the core platform appears bundled, advanced features and ongoing access may represent recurring revenue component. Includes patient management, appointment scheduling, telemedicine, monitoring, training, and research tools.
3. Equipment Financing Services: In-house financing programs enabling customers to acquire chambers through installment payments. Processes over $10 million in financing annually. Revenue generated through interest/financing charges on financed equipment purchases.
4. Customer Care and Maintenance Services: Extended warranty services, preventive diagnostics, component kits, and technical training provided as paid services. Includes recycling and upgrade programs for existing equipment.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

Biobarica manufactures and globally distributes the Revitalair® 430 medium-pressure (1.5 ATA) semi-rigid hyperbaric chamber under medical-device certifications, selling it to medical practices, clinics, and hospitals as part of an integrated treatment system. Each chamber sale is bundled with the Biobarica Global System (BGS) management software, Biobarica Media educational content, Customer Care technical support, and access to Biobarica Financial Services (BFS) in-house equipment financing. The offering targets postoperative recovery, wound healing, pain management, and rehabilitation applications, with over 2 million patients treated across more than 1,000 care centers in 60+ countries.

Product overview

Biobarica offers an integrated hyperbaric oxygen therapy system consisting of the Revitalair® 430 hyperbaric chamber as the core product, supported by the Biobarica Global System (BGS) software platform for clinic management, Biobarica Media for educational content, Customer Care for technical support, and Financial Services for financing options. The system delivers medium-pressure (1.5 ATA) hyperbaric oxygen therapy certified as a medical device worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Revitalair: The hyperbaric chamber product line marketed by Biobarica, specifically the Revitalair 430 model.
• Biobarica Global System (BGS)
• Biobarica Media

Products and services

• Revitalair® 430 Hyperbaric Chamber Medium-pressure (1.5 ATA) semi-rigid monoplace hyperbaric chamber for medical practices, clinics, and hospitals; includes zipperless closing system with dual relief valves, removable stretcher, ten 360° windows, rapid 5-minute pressurization, and is sold as a certified medical device worldwide for postoperative recovery, wound healing, pain management, and rehabilitation.
• Biobarica Global System (BGS) Cloud-based management software platform provided to Biobarica chamber owners; includes appointment scheduling, patient CRM, telemedicine, Hipermed network statistics and protocol recommendations, training modules (medical, scientific, technical, commercial), real-time chamber monitoring, marketing materials library, and research portal for HBOT literature.
• Biobarica Customer Care Customer-care and technical-support service for Biobarica chamber owners covering remote installation assistance, extended warranty, scheduled preventive diagnostics, comprehensive equipment inspection, customized technical training, customizable component kits, recycling and upgrade program, and 24/7 technical support availability.
• Biobarica Financial Services (BFS) In-house equipment financing program for hyperbaric chamber purchases, offering 100% prefunding upfront, deferred payment options, wide approval limits, 2-4 hour credit approvals, DocuSign document signing, financing for A–D credit tiers, and acceptance of tax liens, judgments, and prior bankruptcies with no additional fees.

Quantifiable outcome

• Recovery time reduced from 21 days to 10 days for complex combined surgeries (body contouring, abdominoplasty with liposuction)
• +6 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Fink Engineering: Australian manufacturer of hyperbaric oxygen therapy chambers, including monoplace and multiplace systems for hospitals and clinics. Comparable to Biobarica as a chamber manufacturer targeting medical HBOT applications, with overlapping customer segments.
• Perry Baromedical: Manufacturer of hyperbaric chambers serving hospitals, clinics, and wound care centers globally. Competes head-to-head with Biobarica in the monoplace HBOT chamber category, with similar customer profiles (medical institutions, specialty practices).
• Sechrist Industries: US-based manufacturer of hyperbaric oxygen therapy chambers, including monoplace and multiplace systems used in hospitals and wound care centers. Direct competitor in the same HBOT equipment category, with a long-established US hospital footprint.
• OxyHealth: Manufacturer of portable and chamber-based hyperbaric oxygen therapy systems, including soft-shell and hard-shell chambers. Comparable to Biobarica in targeting private practices, wellness centers, and specialty clinics with HBOT solutions.

Broad incumbents

• Environmental Tectonics Corporation (ETC): Diversified manufacturer of hyperbaric chambers (monoplace and multiplace), as well as aerospace and training systems. A broader incumbent in the HBOT space, competing across multiple chamber types with a more diversified business portfolio.
• HAUX-Life-Support (HAUX Group): German-based manufacturer of hyperbaric chambers for medical, industrial, and special-purpose applications. A broader incumbent offering multiplace and complex chamber systems, overlapping with Biobarica in clinical HBOT equipment.

Emerging players

• AHA Hyperbarics: Provider of hyperbaric chamber solutions and related services focused on specific clinical applications. Emerging player with partial overlap to Biobarica's HBOT equipment focus, particularly in specialty treatment niches.
• Baroks Hyperbaric: Manufacturer and supplier of hyperbaric chamber systems for medical and wellness applications. Emerging player competing in similar private-practice and clinic segments where Biobarica is active.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCgYtHYq5UppdGaHB3_4r1dw
• Facebookfacebook.com/BiobaricaMedicalHyperbaricSystems
• LinkedInlinkedin.com/company/biobarica-hyperbaric-systems
• Instagraminstagram.com/biobaricahyperbaricsystems
• Xx.com/biobarica

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biobarica